Effects of ischemia-reperfusion and pretreatment with mildronate on rat liver mitochondrial function.

Journal Title: Pharmacological Reports - Year 2009, Vol 61, Issue 5

Abstract

Mildronate (3-(2,2,2-trimethylhydrazinium) propionate), which is mostly used in cardiological practice and is considered an anti-ischemic drug, was designed to inhibit carnitine biosynthesis in order to prevent accumulation of cytotoxic intermediate products of fatty acid beta-oxidation. Recently it was shown that the mitochondrial respiratory chain may also be a target for mildronate action. In this study, we aimed to investigate whether mildronate can protect the liver against a 90-min normothermic ischemia/30-min reperfusion-induced mitochondrial dysfunction. Rats were pre-treated for one or two weeks with mildronate (100 mg/kg/day or 200 mg/kg/day) or Ringer solution and subjected to ischemia/reperfusion.We found that ischemia/reperfusion caused a decrease in mitochondrial State 3 respiration rate and in the respiratory control index (RCI), and an increase in State 2 respiration rate with succinate, glutamate + malate and palmitoyl-L-carnitine + malate. One or two weeks of pre-treatment of rats with different doses of mildronate did not reduce the ischemia/reperfusion-induced decrease in the State 3 respiration rate or RCI; however, a one week pre-treatment slightly diminished the increase in the State 2 respiration rate with glutamate + malate substrates. The leakage of the liver enzymes, aspartate aminotransferase, alanine aminotransferase and lactate dehydrogenase, was similar in both the untreated and pre-treated with mildronate groups. No steatotic livers were observed in any experimental groups after mildronate pre-treatment. In conclusion, 90 min of liver ischemia followed by a 30 min reperfusion has a deleterious effect on rat liver mitochondrial function. Mildronate pre-treatment of rats at doses of 100 or 200 mg/kg/day for one or two weeks did not prevent ischemia/reperfusion-induced mitochondrial dysfunction and liver injury.

Authors and Affiliations

Sonata Trumbeckaite, Marius Kincius, Andrius Preidis, Monika Preidiene, Vincentas Veikutis, Vilmante Borutaite, Antanas Gulbinas

Keywords

Related Articles

Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type.

Alzheimer's disease (AD) is the most common type of dementia disorder of elderly affecting millions of people. The pathophysiology of the disease is complex and involves multiple pathways of neuronal damage. Sporadic dem...

Chemical structure of phenothiazines and their biological activity.

Phenothiazines belong to the oldest, synthetic antipsychotic drugs, which do not have their precursor in the world of natural compounds. Apart from their fundamental neuroleptic action connected with the dopaminergic rec...

Nephroprotective effect of cystathionine is due to its diverse action on the kidney and Ehrlich ascites tumor cells.

Tumor cells, unlike normal cells, are characterized by trace cystathionase (CST) activity and sulfane sulfur levels. The present studies aimed to established whether cystathionine (CT), a substrate of cystathionase, can...

Anti-apoptotic effects of hyperoside via inhibition of NR2B-containing NMDA receptors.

Hyperoside (Hyp) is a flavonoid compound isolated from a folk remedy, Rhododendron ponticum L. leaves. It has been shown to have neuroprotective effects both in vivo and in vitro. However, little is known about the effec...

Role of serotonin (5-HT)(1B) receptors in psychostimulant addiction.

Psychostimulant (cocaine, amphetamine and its derivatives) addiction is an important health problem with implications in social and economic life. Although mesocorticolimbic dopamine system plays a crucial role in the me...

Download PDF file
  • EP ID EP83333
  • DOI -
  • Views 125
  • Downloads 0

How To Cite

Sonata Trumbeckaite, Marius Kincius, Andrius Preidis, Monika Preidiene, Vincentas Veikutis, Vilmante Borutaite, Antanas Gulbinas (2009). Effects of ischemia-reperfusion and pretreatment with mildronate on rat liver mitochondrial function.. Pharmacological Reports, 61(5), 859-869. https://europub.co.uk./articles/-A-83333